The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis
Liping Zhang(Chinese University of Hong Kong), Bei Jin(Sun Yat-sen University), Peilong Lai(Guangdong General Hospital), Hongle Li(Shanghai Jiao Tong University), Jingxuan Pan(Heilongjiang Bayi Agricultural University), Qianyun Ye(Sun Yat-sen University), Chang Liu(Beihang University), Yanli Jin(Jinan University), Yang Luo(Sun Yat-sen University), Jinqiu Zhong(Jinan University)
Cited by 0
Related Papers
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
|Cancer Research|2010|332
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
|Journal of Hematology & Oncology|2018|189
Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
|Molecular Cancer|2010|108
Farnesyltransferase Inhibitors Induce DNA Damage via Reactive Oxygen Species in Human Cancer Cells
|Cancer Research|2005|105